As of September 30, 2025, Inspire Veterinary Partners Inc. has 3.64M shares outstanding.
| Shares Outstanding | 3.64M |
As of September 30, 2025, Inspire Veterinary Partners Inc. maintains a current ratio of 0.39, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 410.61, indicating elevated leverage, while an interest coverage ratio of -3.99 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.39 |
| Quick Ratio | 0.30 |
| Debt / Equity | 410.61 |
| Debt / EBITDA | -2.55 |
| Interest Coverage | -3.99 |
Over the twelve months ended September 30, 2025, Inspire Veterinary Partners Inc. posted a negative return on equity (ROE) of -331.80, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -51.53, reflecting losses generated across the asset base. The company generates approximately 137,699.21 in revenue per employee across its workforce of 113.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 23.65 indicates how many times Inspire Veterinary Partners Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | -331.80 |
| Return on Assets (ROA) | -51.53 |
| Revenue Per Employee | 137,699.21 |
| Employee Count | 113.00 |
| Inventory Turnover | 23.65 |
As of the close on November 13, 2026, Inspire Veterinary Partners Inc.'s stock has declined approximately 99.99% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| 52-Week Price Change | -99.99% |
Over the twelve months ended September 30, 2025, Inspire Veterinary Partners Inc. generated 15.56M in revenue and converted that into -11.94M in net income, yielding earnings per share of -6.08. EBITDA reached -6.71M, while operating income came in at -8.97M.
| Revenue | 15.56M |
| Gross Profit | 3.01M |
| Operating Income | -8.97M |
| Pretax Income | -11.94M |
| Net Income | -11.94M |
| EBITDA | -6.71M |
| EBIT | -8.13M |
| Earnings Per Share (EPS) | -6.08 |
As of September 30, 2025, Inspire Veterinary Partners Inc. holds 2.91M in cash and equivalents against 17.12M in total debt, resulting in a net debt position of 14.79M. Total book value stands at 4.17M, with working capital of -5.89M providing operational flexibility.
| Cash & Cash Equivalents | 2.91M |
| Total Debt | 17.12M |
| Net Debt | 14.79M |
| Equity (Book Value) | 4.17M |
| Book Value Per Share | 1.15 |
| Working Capital | -5.89M |
Inspire Veterinary Partners Inc. produced -4.23M in operating cash flow over the twelve months ended September 30, 2025. After subtracting -108,143.00 in capital expenditures, free cash flow totaled -4.34M - equivalent to -2.21 per share.
| Operating Cash Flow | -4.23M |
| Capital Expenditures | -108,143.00 |
| Free Cash Flow | -4.34M |
| FCF Per Share | -2.21 |
Over the twelve months ended September 30, 2025, Inspire Veterinary Partners Inc. posted a gross margin of 19.36, reflecting its pricing power and cost economics. The operating margin of -57.63 and net profit margin of -76.75 provide insight into operational efficiency.
| Gross Margin | 19.36 |
| Operating Margin | -57.63 |
| Pretax Margin | -76.75 |
| Profit Margin | -76.75 |
| EBITDA Margin | -43.10 |
Inspire Veterinary Partners Inc.'s most recent stock split took place on January 27, 2025 with a 25:1 split ratio.
| Last Split Date | 1/27/2025 |
| Split Ratio | 25:1 |